Charakterisierung von Lebertumoren nach kontrastverstärkter Sonographie und digitaler GraustufenbestimmungSascha Santosh Chopra111.1231.1.11.1.241.1.351.1.41.1.561.1.61.271.2.181.2.29101.2.311121.3131.3.114151.3.21.3.31617548#21418581#132191.3.4201.4212222.12.2232.2.1242.2.22.2.32.2.4252.32.3.12.3.226577#282272.3.3455#32528458#2352.4292.52.62.7303303.1473#248313.23.2.132333.2.234353.336522#3573.3.13.3.237335#31038338#3053.43.4.139603#300600#30040605#302605#3023.4.241605#302605#3023.4.3423.4.43.4.543606#3033.4.6443.545605#302605#3024464.14.1.1474.1.2484.1.34950515253544.1.455564.24.2.14.2.24.2.357584.3594.4 Literaturverzeichnis Danksagung Lebenslauf Eidesstattliche ErklärungdeInhaltsverzeichnisHilfe Literaturverzeichnis [1] Schiff, E.; Sorell, MF. and Maddrey, WC. (2003): Schiff´s diseases of the liver, 9. ed., Lippincott Williams and Wilkins,

Philadelphia

. [2] Karhunen, PJ. (1986): Benign hepatic tumors and tumorlike conditions in men, J Clinical Pathology, (vol. 39), No. 2, pp.183-188. [3] Erhardt, A.; Theobald, I.; Petry, W. and al., et (2002): Hepatozelluläres Karzinom: Steigende Inzidenz der Hepatitis-C-bedingten Fälle einer Universitätsklinik in Deutschland, Deutsche Med Wochenschr, (vol. 127), No. 50, pp.2665-2668. [4] Blumgart, L.H., Fong, Y. (2000): Surgery of the liver and billiary tract (vol. 2), 3. ed., W.B. Saunders,

London

, ISBN 0-7020-2501-1. [5] Minagawa, M. and Makuuchi, M. (2003): Surgical treatment of colorectal liver metastasis, Nippon Geka Gakkai Zasshi, (vol. 104), No. 10, pp.721-9. [6] Llovet, J. M.; Burroughs, A. and Bruix, J. (2003): Hepatocellular carcinoma, Lancet, (vol. 362), No. 9399, pp.1907-17. [7] Braunwald, E.; Fauci, A.; Kasper, D.; Hauser, S.; Longo, D. and Jameson, L. (2001): Harrison´s principles of internal medicine (vol. 1), 15. ed., McGraw-Hill,

New York

, ISBN 0-07-007272-8. [8] Gerard, B. and Bleiberg, H. (2004): Treatment of hepatocarcinoma, Curr Oncol Rep, (vol. 6), No. 3, pp.184-91. [9] Graham, E.; Cohen, A. W.; Soulen, M. and Faye, R. (1993): Symptomatic liver hemangioma with intra-tumor hemorrhage treated by angiography and embolization during pregnancy, Obstet Gynecol, (vol. 81), No. 5 ( Pt 2), pp.813-6. [10] Wanless, I. R.; Albrecht, S.; Bilbao, J.; Frei, J. V.; Heathcote, E. J.; Roberts, E. A. and Chiasson, D. (1989): Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome, Mod Pathol, (vol. 2), No. 5, pp.456-62. [11] Mathieu, D.; Kobeiter, H.; Cherqui, D.; Rahmouni, A. and Dhumeaux, D. (1998): Oral contraceptive intake in women with focal nodular hyperplasia of the liver, Lancet, (vol. 352), No. 9141, pp.1679-80. [12] Rooks, J. B.; Ory, H. W.; Ishak, K. G.; Strauss, L. T.; Greenspan, J. R.; Hill, A. P. and Tyler, C. W., Jr. (1979): Epidemiology of hepatocellular adenoma. The role of oral contraceptive use, Jama, (vol. 242), No. 7, pp.644-8. [13] Grazioli, Luigi; Federle, Michael and Tomoaki, Ichikawa (2000): Liver adenomatosis: Clinical, histopathologic, and imaging findings in 15 patients, Radiology, No. 216, pp.395-402. [14] Ferrell, L. D. (1993): Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report, Am J Surg Pathol, (vol. 17), No. 5, pp.525-9. [15] Hosten, N.; Steger, W.; Bechstein, W. O. and al., et (1997): Vaskularisationsmuster in fokalen Leberläsionen: Vergleich der nativen und signalverstärkten amplitudenmodulierten Farbduplexsonographie, Fortschr Röntgenstr, (vol. 166), No. 6, pp.507-513. [16] Albrecht, T.; Hoffmann, C. and Stephan, A. (2001): Phase-Inversion Sonography During the Liver-Specific Late Phase of Contrast Enhancement, AJR Am J Roentgenol, No. 176, pp.1191-1198. [17] Choi, Byung Ihn; Kim, Tae Kyoung; Han, Joon Koo; Chung, JW; Park, JH and Han, MC (1996): Power Doppler versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors., Radiology, No. 200, pp.55-58. [18] Hosoki, T.; Mitomo, M.; Choi, S.; Miyahara, N.; Ohtani, M. and Morimoto, K. (1997): Visualisation of tumor vessels in hepatocellular carcinoma: power Doppler compared with color Doppler and angiography, Acta Radiol, No. 38, pp.422-427. [19] Vilanova, J. C.; Barcelo, J.; Smirniotopoulos, J. G.; Perez-Andres, R.; Villalon, M.; Miro, J.; Martin, F.; Capellades, J. and Ros, P. R. (2004): Hemangioma from head to toe: MR imaging with pathologic correlation, Radiographics, (vol. 24), No. 2, pp.367-85. [20] Gramiak, R. and Shah, P. M. (1968): Echocardiography of the aortic root, Invest Radiol, (vol. 3), No. 5, pp.356-66. [21] Albrecht, T.; Blomley, M. J.; Heckemann, R. A.; Cosgrove, D. O.; Jayaram, V.; Butler-Barnes, J.; Eckersley, R. J.; Hoffmann, C. W. and Bauer, A. (2000): Stimulierte akustische Emission mit dem Ultraschall-Kontrastmittel Levovist: Ein klinisch nutzbarer Kontrasteffekt mit leberspezifischen Eigenschaften, Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, (vol. 172), No. 1, pp.61-7. [22] Bertolotto, M.; Dalla Palma, L.; Quaia, E. and al., et (2000): Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results, Eur J Radiol, (vol. 10), No. 9, pp.1369-1376. [23] Dietrich, C. F. (2002): Signalverstärkte Sonographie verbessert Nachweis von Leberraumforderungen, Deutsches Ärzteblatt, (vol. 99), No. 24, pp.1666-1674. [24] Becker, Dirk; Jenett, M.; Behren, P.; Norka, V. and Lowery, C. (1999): Ensemble Contrast Imaging in der Ultraschalldiagnostik -Technologie und klinische Anwendung, electromedica, (vol. 2), No. 67, pp.111-115. [25] Leen, E.; Angerson, W. J.; Yarmenitis, S.; Bongartz, G.; Blomley, M.; Del Maschio, A.; Summaria, V.; Maresca, G.; Pezzoli, C. and Llull, J. B. (2002): Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions, Eur J Radiol, (vol. 41), No. 3, pp.200-6. [26] Albrecht, T.; Hoffmann, C.; Schettler, S. and al., et (2000): B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans, Radiology, (vol. 216), No. 1, pp.273-278. [27] Burns, P. N.; Wilson, S. R. and Simpson, D. H. (2000): Pulse inversion imaging of liver blood flow: improved method for characterizing fokal masses with microbubble contrast, Invest Radiol, (vol. 35), No. 1, pp.58-71. [28] Solbiati, L.; Martegani, A.; Leen, E.; Correas, J. M.; Burns, P. N. and Becker, D. (2003): Contrast-Enhanced Ultrasound of Liver Diseases, 1. ed., Springer-Verlag Italien,

Mailand

. [29] Solbiati, L. (2001): Radiofrequency thermal ablation of hepatic metastases., European Journal of Ultrasound, (vol. 13), No. 2, pp.149-158. [30] Dietrich, C. F. and Becker, D. (2002): Signalverstärkte Farbdopplersonographie des Abdomens, Wissenschaftliche Buchreihe Byk Gulden,

Konstanz

. [31] Mulvagh, S.; DeMaria, A.; Feinstein, S.; Burns, P. N. and Kaul, S. (2000): Contrast echocardiography: current and future applications., Journal of American Society of Echocardiography, (vol. 13), No. 4, pp.331-342. [32] Senior, R. (2000): Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue., Echocardiography, (vol. 17), No. 8, pp.705-711. [33] Senior, R.; Kaul, S.; Soman, P. and Lahiri, A. (2000): Power doppler harmonic imaging: a feasibility study of a new technique for the assesment of myocardial perfusion., American Heart Journal, No. 139, pp.245-251. [34] Kaps, M.; Seidel, G.; Bokor, D.; Modrau, B. and Algermissen, C. (1999): Safety and ultrasound-enhancing potentials of a new sulfur hexaflouridecontaining agent in the cerebral circulation., Journal of Neuroimaging, (vol. 9), No. 3, pp.150-154. [35] Morel, D. R.; Schwieger, I.; Hohn, L.; Terrettaz, J.; Llull, J. B.; Cornioley, Y. A. and Schneider, M. (2000): Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging, Invest Radiol, (vol. 35), No. 1, pp.80-5. [36] Bokor, D.; Chambers, J. B.; Rees, P. J.; Mant, T. G.; Luzzani, F. and Spinazzi, A. (2001): Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease, Invest Radiol, (vol. 36), No. 2, pp.104-9. [37] Hope Simpson, D.; Chin, C.T. and Burns, P. N. (1999): Pulse inversion doppler: a new method for detecting nonlinear echoes from microbubble contrast agents, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, (vol. 46), pp.372-382. [38] Nino-Murcia, M.; Olcott, E. W.; Jeffrey, R. B., Jr.; Lamm, R. L.; Beaulieu, C. F. and Jain, K. A. (2000): Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT, Radiology, (vol. 215), No. 3, pp.746-51. [39] Savellano, D. H.; Kostler, H.; Baus, S.; Mossinger, M.; Gratz, K. F.; Weimann, A. and Galanski, M. (2004): Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging, Invest Radiol, (vol. 39), No. 5, pp.305-12. [40] Kim, Tae Kyoung; Choi, Byung Ihn; Han, Joon Koo; Hong, Hye-Suk; Park, Seong Ho and Moon, Sung Gyu (2000): Hepatic Tumors: Contrast Agent-Enhancement Patterns with Pulse-Inversion Harmonic US, Radiology, (vol. 216), No. 2, pp.411-417. [41] Kim, K. W.; Kim, T. K.; Han, J. K.; Kim, A. Y.; Lee, H. J.; Park, S. H.; Kim, Y. H. and Choi, B. I. (2000): Hepatic hemangiomas: spectrum of US appearances on gray-scale, power Doppler, and contrast-enhanced US, Korean J Radiol, (vol. 1), No. 4, pp.191-7. [42] Kehagias, D.; Moulopoulos, L.; Antoniou, A.; Hatziioannou, A.; Smyrniotis, V.; Trakadas, S.; Lahanis, S. and Vlahos, L. (2001): Focal nodular hyperplasia: imaging findings, Eur Radiol, (vol. 11), No. 2, pp.202-12. [43] Oudkerk, M.; Torres, C. G.; Song, B.; Konig, M.; Grimm, J.; Fernandez-Cuadrado, J.; Op de Beeck, B.; Marquardt, M.; van Dijk, P. and de Groot, J. C. (2002): Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT, Radiology, (vol. 223), No. 2, pp.517-24. [44] Semelka, R. C. and Helmberger, T. K. (2001): Contrast agents for MR imaging of the liver, Radiology, (vol. 218), No. 1, pp.27-38. [45] Pirovano, G.; Vanzulli, A.; Marti-Bonmati, L.; Grazioli, L.; Manfredi, R.; Greco, A.; Holzknecht, N.; Daldrup-Link, H. E.; Rummeny, E.; Hamm, B.; Arneson, V.; Imperatori, L.; Kirchin, M. A. and Spinazzi, A. (2000): Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions, AJR Am J Roentgenol, (vol. 175), No. 4, pp.1111-20. [46] Gambarin-Gelwan, M.; Wolf, D. C.; Shapiro, R.; Schwartz, M. E. and Min, A. D. (2000): Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation, Am J Gastroenterol, (vol. 95), No. 6, pp.1535-8. [47] Carter, R.; Hemingway, D.; Cooke, T. G.; Pickard, R.; Poon, F. W.; McKillop, J. A. and McArdle, C. S. (1996): A prospective study of six methods for detection of hepatic colorectal metastases, Ann R Coll Surg Engl, (vol. 78), No. 1, pp.27-30. [48] Hagspiel, K. D.; Neidl, K. F.; Eichenberger, A. C.; Weder, W. and Marincek, B. (1995): Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US, Radiology, (vol. 196), No. 2, pp.471-8. [49] Hohmann, J.; Skrok, J.; Puls, R. and Albrecht, T. (2003): Charakterisierung fokaler Leberläsionen mit kontrastmittelgestütztem "low MI real time" Ultraschall und SonoVue, Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, (vol. 175), No. 6, pp.835-43. [50] Folkman, J. (2002): Role of angiogenesis in tumor growth and metastasis, Semin Oncol, (vol. 29), No. 6 Suppl 16, pp.15-8. [51] Hosten, N.; Puls, R.; Bechstein, W. O. and Felix, R. (1999): Focal liver lesions: Doppler ultrasound, Eur Radiol, (vol. 9), No. 3, pp.428-35. [52] Basilico, R.; Blomley, M. J.; Harvey, C. J.; Filippone, A.; Heckemann, R. A.; Eckersley, R. J. and Cosgrove, D. O. (2002): Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?, Eur J Radiol, (vol. 41), No. 3, pp.184-91. [53] Cedrone, A.; Pompili, M.; Sallustio, G.; Lorenzelli, G. P.; Gasbarrini, G. and Rapaccini, G. L. (2001): Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures, Am J Gastroenterol, (vol. 96), No. 6, pp.1854-9. [54] Schneider, M. (2001): Bubbles and microcirculatory disorders, Eur Radiol, (vol. 11 Suppl 3), pp.E1-5. [55] Numata, K.; Tanaka, K.; Kiba, T.; Saito, S.; Ikeda, M.; Hara, K.; Tanaka, N.; Morimoto, M.; Iwase, S. and Sekihara, H. (2001): Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings, J Ultrasound Med, (vol. 20), No. 2, pp.89-98. [56] Basilico, R.; Blomley, M. J.; Cosgrove, D. O.; Liull, J. B.; Broillet, A.; Bauer, A. and Bonomo, L. (2002): The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys, Acad Radiol, (vol. 9 Suppl 2), pp.S380-1. [57] Youk, J. H.; Kim, C. S. and Lee, J. M. (2003): Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions, J Ultrasound Med, (vol. 22), No. 9, pp.897-910. [58] Barr, R. (2002): Seeking consensus: contrast ultrasound in radiology, Eur J Radiol, (vol. 41), No. 3, pp.207-16. [59] Bauer, A.; Solbiati, L. and Weissman, N. (2002): Ultrasound imaging with SonoVue: low mechanical index real-time imaging, Acad Radiol, (vol. 9 Suppl 2), pp.S282-4. [60] Kissel, A.; Rixe, O.; Methlin, A.; Nabet, M.; Tranquart, F.; Rubini, B.; Jafaar, S. and Gaucher, H. (2001): Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers, J Radiol, (vol. 82), No. 11, pp.1621-5. [61] Maeda, K.; Utsu, M. and Kihaile, P. E. (1998): Quantification of sonographic echogenicity with grey-level histogram width: a clinical tissue characterization, Ultrasound Med Biol, (vol. 24), No. 2, pp.225-34. [62] Dietrich, C. F. (2002): Kontrastverstärkte 3D-Bildgebung unter Echtzeitbedingungen, eine neue Technik, Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, (vol. 174), No. 2, pp.160-3. [63] Yamamoto, K.; Shiraki, K.; Nakanishi, S.; Deguchi, M.; Sugimoto, K.; Sakai, T.; Ohmori, S.; Murata, K.; Fuke, H.; Hashimoto, A.; Shimizu, A.; Okuda, Y. and Nakano, T. (2003): The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors, Int J Oncol, (vol. 22), No. 2, pp.353-8. [64] Fischer, T.; Muhler, M.; Kroncke, T. J.; Lembcke, A.; Rudolph, J.; Diekmann, F.; Ebeling, V.; Thomas, A.; Greis, C.; Hamm, B. and Filimonow, S. (2004): Die Transplantatniere: Zeit-Intensitäts-Kurven-basierte Evaluation der arteriellen Anflutungsphase mittels Echosignalverstärker unmittelbar postoperativ, Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, (vol. 176), No. 4, pp.472-7. [65] Dill-Macky, M. J.; Burns, P. N.; Khalili, K. and Wilson, S. R. (2002): Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US, Radiology, (vol. 222), No. 1, pp.95-102. [66] Bezy-Wendling, J.; Kretowski, M. and Rolland, Y. (2003): Hepatic tumor enhancement in computed tomography: combined models of liver perfusion and dynamic imaging, Comput Biol Med, (vol. 33), No. 1, pp.77-89. [67] Kim, T. K.; Choi, B. I.; Han, J. K.; Hong, H. S.; Park, S. H. and Moon, S. G. (2000): Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US, Radiology, (vol. 216), No. 2, pp.411-7. [68] Strobel, D.; Hoefer, A.; Martus, P.; Hahn, E. G. and Becker, D. (2001): Dynamic contrast-enhanced power Doppler sonography improves the differential diagnosis of liver lesions, Int J Colorectal Dis, (vol. 16), No. 4, pp.247-56.